IL-1β and IL-6 act synergistically with TNF-α to alter cardiac contractile function after burn trauma

Shock

Volumn 18, Issue 4, 2002, Pages 360-366

  Maass, David L ^a   White, Jean ^a   Horton, Jureta W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cardiac contraction and relaxation; Cardiomyocyte injury; Cytokine mediated cardiac contractile dysfunction; Inflammatory cytokines

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BURN; CELL CULTURE; DRUG EFFECT; HEART CONTRACTION; HEART MUSCLE CELL; HEMODYNAMICS; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BURNS; CELLS, CULTURED; HEMODYNAMIC PROCESSES; INTERLEUKIN-1; INTERLEUKIN-6; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036781708     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200210000-00012     Document Type: Article

References (37)

1. Adams HR, Baxter CR, Parker JL, Senning R: Development of acute burn shock in unresuscitated guinea pigs. Circ Shock 8:613-620, 1981.
2. Adams HR, Baxter CR, Izsenberg SD: Decreased contractility and compliance of the left ventricle as complications of thermal trauma. Am Heart J 108:1477-1487, 1984.
3. Horton JW, Garcia NM, White DJ, Keffer J: Postburn cardiac contractile and biochemical markers of postburn cardiac injury. J Am Coll Surg 181:289-298. 1995.
4. Murphy JT, Horton JW, Purdue GF, Hunt JL: Evaluation of Troponin-I as an indicator of cardiac dysfunction after thermal injury. J Trauma 45:700-704, 1998.
5. Maass DL, Peters Hybki D, White J, Horton JW: The time course of cardiac NF-κB activation and TNF-α secretion by cardiac myocytes after burn injury. Shock 17(4):293-299, 2002.
6. Turbeville T, Horton JW: Burn trauma stimulates cardiomyocyte production of TNF-α and nitric oxide (NO). Shock 9(Suppl):8, 1998.
7. Horton JW, Maass D, White J, Sanders B: Hypertonic saline dextran suppresses burn-related cytokine secretion by cardiomyocytes. Am J Physiol 280:H1591-H1601, 2001.
8. Croft C, White DJ, Maass DL, Peters Hybki D, Horton JW: The role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-α. Am J Physiol 208:H1970-H1981, 2001.
9. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 183:315-321, 2001.
10. Elenkov IJ, Webster EL, Torpy DJ, Chrousos GP: Stress, corticotropin-releasing hormone, glucocorticoids, and the immune/inflammatory response: acute and chronic effects. Ann NY Acad Sci 876:1-13, 1999.
11. Kushner I: Semantics, inflammation, cytokines and common sense. Cytokine Growth Factor Rev 9:191-196, 1998.
12. Yokoyama T, Vaca L, Rossen RD, Durante W, Mann DL: Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 92:2303-2312, 1993.
13. Mann DL, Young JB: Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105:897-904, 1994.
14. McMurray J, Abdullah I, Dargie HJ, Shapiro D: Increased concentrations of tumor necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 66:356-358, 1991.
15. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH, Leung JM, Mangano DT, Greenfield LJ, Rankin JS: Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 108:626-635, 1994.
16. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL: Hemodynamic regulation of tumor necrosis factor-α and protein expression in adult feline myocardium. Circ Res 81:187-195, 1997.
17. Meldrum DR, Cleveland Jr JC, Cain BS, Meng X, Harken AH: Increased myocardial tumor necrosis factor-α in a crystalloid-perfused model of cardiac ischemia-reperfusion injury. Ann Thorac Surg 65:439-443, 1998.
18. Last-Barney K, Homon CA, Faanes RB, Merluzzi VJ: Synergistic and overlapping activities of tumor necrosis factor-α and IL-1. J Immunol 141:527-530, 1988.
19. Cain BS, Meldrum DR, Dinarello CA, Meng X, Joo KA, Banerjee A, Harken AH: Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function. Crit Care Med 27:1309-1318, 1999.
20. Okusawa S, Gelfand JA, Ikejima T, Connolly RJ, Dinarello CA: Interleukin 1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 81:1162-1172, 1988.
21. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE: Tumor necrosis factor-α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949-958, 1996.
22. Maass DL, Horton JW: Burn trauma stimulates cardiomyocyte secretion of interleukins (IL-1β and IL-6). Shock 13(Suppl):9, 2000.
23. Dalrymple SA, Lucian LA, Slattery R, McNeil T, Aud DM, Fuchino S, Lee F, Murray R: Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 63: 2262-2268, 1995.
24. Dalrymple SA, Slattery R, Aud DM, Krishna M, Lucian LA, Murray R: Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection. Infect Immun 64:3231-3235, 1996.
25. DiPersio JF: Colony-stimulating factors: enhancement of effector cell function. Cancer Surv 9:81-113, 1990.
26. Johnson JL, Moore EE, Tamura DY, Zallen G, Biffl WL, Silliman CC: Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release. J Surg Res 66:91-94, 1998.
27. Meng ZH, Dyer K, Billiar TR, Tweardy DJ: Essential role for IL-6 in post-resuscitation inflammation in hemorrhagic shock. Am J Physiol 280:C343-C351, 2001.
28. Horton JW, White J, Maass DL: Protein kinase C inhibition improves ventricular function after thermal trauma. J Trauma 44:254-265, 1998.
29. O'Riordain MG, O'Riordain DS, Molloy RG, Mannick JA, Rodrick ML: Dosage and timing of anti-TNF-α antibody treatment determine its effect on resistance to sepsis after injury. J Surg Res 64:95-101, 1996.
30. Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Ha HAB, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A: P55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: a randomized controlled multicenter trial. Ro 45-20-81 study group. J Am Med Assoc 277:1531-1538, 1997.
31. Gebhard F, Pfetsch H, Steinbach G, Strecker W, Kinzl L, Brückner UB: Is interleukin 6 an early marker of injury severity following major trauma in humans? Arch Surg 135:291-295, 2000.
32. O Nuallain EM, Puri P, Mealy K, Reen DJ: Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma. Clin Immunol Immunopathol 76:96-101, 1995.
33. Tang GJ, Kuo CD, Yen TC, Juo HS, Chan KHJ, Yien HW, Lee TY: Perioperative plasma concentrations of tumor necrosis factor-α and interleukin-6 in infected patients. Crit Care Med 24:423-428, 1996.
34. Giroir BP, Horton JW, White DJ, McIntyre KL, Lin CQ: Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol 261:H118-H124, 1994.
35. Giroir BP, Johnson JH, Brown T, Allen GA, Beutler B: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest 90: 693-698, 1992.
36. Kapadia SR, Lee J, Torre-Amione G, Birdsall HH, Mann DL: Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 96:1042-1052, 1995.
37. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovits R, Mann DL: Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 92:1487-1493, 1995.